Designer natriuretic peptides: a vision for the future of heart failure therapeutics. - Wikidata - wikimedia - TriplyDB

Designer natriuretic peptides: a vision for the future of heart failure therapeutics.

Designer natriuretic peptides: a vision for the future of heart failure therapeutics.

http://www.wikidata.org/entity/Q37911516

about

Phosphodiesterase 9A controls nitric-oxide-independent cGMP and hypertrophic heart disease Atrial natriuretic peptide in cardiovascular biology and disease (NPPA)A heart-adipose tissue connection in the regulation of energy metabolism.Molecular Physiology of Membrane Guanylyl Cyclase Receptors.A New Chimeric Natriuretic Peptide, CNAAC, for the Treatment of Left Ventricular Dysfunction after Myocardial Infarction New pulmonary hypertension model in conscious dogs to investigate pulmonary-selectivity of acute pharmacological interventions.Distinct submembrane localisation compartmentalises cardiac NPR1 and NPR2 signalling to cGMP.A big-hearted molecule

P2860

Q24323316-F1D2FDAD-6993-4A30-A032-82CC6B9B6C2B Q28082833-EAB3A5AF-3BFE-4056-9DE4-F590CFE610E4 Q38168030-C473D193-EA8D-4E36-BF4B-ED403C9AAEBB Q38794203-09C2E7A3-A6C8-4100-ABC4-164EB5EC8831 Q41564348-2F157E49-AC30-424E-B4BC-986CCFEEC641 Q47228768-B62F3745-47E3-4DEA-9CDA-2D5593E7065E Q55379674-0F838CF4-C091-4B4A-BB0D-0DC74AD1C005 Q59053624-9A2992F4-4BA3-4467-A9D4-9507F85CE8FD

P2860

Designer natriuretic peptides: a vision for the future of heart failure therapeutics.

http://www.wikidata.org/entity/Q37911516

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Designer natriuretic peptides: a vision for the future of heart failure therapeutics.

@en

Designer natriuretic peptides: a vision for the future of heart failure therapeutics.

@nl

type

label

Designer natriuretic peptides: a vision for the future of heart failure therapeutics.

@en

Designer natriuretic peptides: a vision for the future of heart failure therapeutics.

@nl

prefLabel

Designer natriuretic peptides: a vision for the future of heart failure therapeutics.

@en

Designer natriuretic peptides: a vision for the future of heart failure therapeutics.

@nl

P1433

Q37911516-868286A6-7143-4BD5-AA0A-14A9671CA69A

P1476

Q37911516-F985959C-E4D9-4F24-A569-2B17BA3234CC

P2093

Q37911516-62876CFD-686F-49A7-B6B0-B729919757A8

Q37911516-BDF57DC2-55F6-47F7-9A04-7C1C78C566FF

P2860

Q37911516-22B21823-77C6-4179-BB63-7D191B2705F2

Q37911516-25810CE0-DD6D-440D-A270-63E6CED48709

Q37911516-2C2B2C6A-514B-4616-B0F6-99A37EAD85E1

Q37911516-34B62DC7-26EE-49E6-82FB-FD124A0448EB

Q37911516-37523015-59F2-4940-852E-FDAD4AA28CB1

Q37911516-39C913D8-0817-43E4-A164-CB6F4B0371E3

Q37911516-3A94B2F2-A874-49B6-898F-7BF7B3568583

Q37911516-409B29BE-D91A-47B9-8A89-1826F6987682

Q37911516-40A33A95-AB90-4790-B4B9-041BB09B6208

Q37911516-42E18115-6044-496F-B48E-68E2F0202744

P304

Q37911516-729ED7C7-414A-491E-AB17-0A0812A7553B

P31

Q37911516-7B8EF55B-D441-477A-83C2-2657B08C9BFF

P356

Q37911516-F9F88AB5-8151-45D2-B55C-976FC47CF40F

P433

Q37911516-B11E8503-DC83-45D9-81CF-BC2B41040764

P478

Q37911516-6721D643-BFF9-4B3B-B8BB-CD443261C710

P577

Q37911516-5DF6935A-B7E8-4295-AF61-A0B5EB386A1E

P698

Q37911516-E21AA2AF-6B8A-48FB-BC4E-21DEAFE01195

P921

Q37911516-A9027994-5C83-4E34-B225-B594C352A14F

P356

P1433

Canadian Journal of Physiology and Pharmacology

P1476

Designer natriuretic peptides: a vision for the future of heart failure therapeutics.

@en

P2093

John C Burnett

http://www.w3.org/2001/XMLSchema#string

Rosita Zakeri

http://www.w3.org/2001/XMLSchema#string

P2860

Short-term risk of death after treatment with nesiritide for decompensated heart failure: a pooled analysis of randomized controlled trials

Natriuretic peptide receptor-B in adult rat ventricle is predominantly confined to the nonmyocyte population

Gene expression, secretion, and autocrine action of C-type natriuretic peptide in cultured adult rat cardiac fibroblasts

Detection of endogenous B-type natriuretic peptide at very low concentrations in patients with heart failure.

Simultaneous assessment of unprocessed ProBNP1-108 in addition to processed BNP32 improves identification of high-risk ambulatory patients with heart failure.

Differential regulation of natriuretic peptide receptor messenger RNAs during the development of cardiac hypertrophy in the rat.

Quantitative mass spectral evidence for the absence of circulating brain natriuretic peptide (BNP-32) in severe human heart failure

A novel chimeric natriuretic peptide reduces cardiomyocyte hypertrophy through the NHE-1-calcineurin pathway.

Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure.

Pharmacodynamics of a novel designer natriuretic peptide, CD-NP, in a first-in-human clinical trial in healthy subjects.

P304

593-601

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1139/Y11-048

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

89

http://www.w3.org/2001/XMLSchema#string

P577

2011-08-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21815778

http://www.w3.org/2001/XMLSchema#string

P921